TipRanks
Go Ultimate55% OFF

Koa Shoji Holdings Co., Ltd. (9273) AI Stock Analysis

JP:9273

Koa Shoji Holdings Co., Ltd.

(TSE/TYO:9273)

Select Model
Rating:83Outperform
Price Target:JPY 998.00â–²(18.95% Upside)
Action:reiterated
Date:08/17/26

The overall score is driven primarily by strong financial performance—steady revenue growth, expanding margins, low and declining leverage, and improving cash generation—which supports a robust underlying business. An attractive valuation, with a low earnings multiple and moderate dividend yield, further boosts the score and offers potential value for shareholders. Technicals are supportive but not emphatically bullish, reflecting stable, slightly positive momentum rather than a strong trend, which moderates the score slightly while still keeping it solidly in the higher range.

Positive Factors
Improving ProfitabilityThe sustained improvement in operating and net margins indicates stronger profitability across the business rather than reliance on revenue growth alone. Higher margins can support reinvestment, strengthen resilience against cost pressure, and provide a durable base for earnings generation over the next several quarters.
Negative Factors
Uneven Revenue GrowthThe inconsistent year-to-year revenue pattern makes the company’s growth profile less predictable than its latest result alone suggests. Periods of flat sales can limit operating leverage, complicate planning, and make sustained earnings expansion more dependent on renewed top-line momentum.

Koa Shoji Holdings Co., Ltd. (9273) vs. iShares MSCI Japan ETF (EWJ)

-10%-5%0%5%10%15%20%25%JP:9273+7.29%EWJ+15.87%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
JPY 35.34B
Dividend Yield
2.15%
Average Volume (3M)
66.77K
Price to Earnings (P/E)
9.4
Beta (1Y)
0.77
Revenue Growth
6.06%
EPS Growth
3.04%
Country
Japan
Employees
318
Sector
General
Sector Strength
55
Industry
Drug Manufacturers - Specialty & Generic

Koa Shoji Holdings Co., Ltd. Business Overview & Revenue Model

Company Description

Koa Shoji Holdings Co.,Ltd., established in 1991 and headquartered in Yokohama, Japan, operates through its subsidiaries, engaging in a diverse array of pharmaceutical activities. The company sources and distributes active pharmaceutical ingredients...

How the Company Makes Money

null

Koa Shoji Holdings Co., Ltd. Financial Statement Overview

Summary

Financial performance is strong, driven by steady revenue growth, widening operating and net margins, solid 11–13% ROE, a conservative and strengthening balance sheet with declining debt-to-equity, and improving but still somewhat volatile cash flows, indicating a financially resilient and profitable business with moderate growth upside.

Income Statement

86Very Positive

Balance Sheet

83Very Positive

Cash Flow

78Positive
Financial statement breakdown
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue24.68B24.68B23.27B22.13B22.05B20.35B
Gross Profit8.00B8.00B7.70B6.64B6.44B5.93B
EBITDA6.04B6.09B6.08B5.11B4.79B4.44B
Net Income3.75B3.75B3.64B2.95B2.69B2.36B
Balance Sheet
Total Assets39.53B39.53B36.11B32.00B28.46B26.25B
Cash, Cash Equivalents and Short-Term Investments17.58B17.58B14.92B13.95B10.77B9.12B
Total Debt3.32B3.32B2.46B2.84B3.18B3.56B
Total Liabilities8.35B8.35B7.99B6.95B7.54B7.58B
Stockholders Equity31.18B31.18B28.12B25.05B20.92B18.67B
Cash Flow
Free Cash Flow03.92B1.89B2.39B2.47B1.65B
Operating Cash Flow07.59B3.78B3.83B2.74B2.09B
Investing Cash Flow0-8.15B-1.28B-1.47B-304.11M-477.33M
Financing Cash Flow0189.08M-938.67M795.25M-812.06M-804.93M

Koa Shoji Holdings Co., Ltd. Technical Analysis

Technical Analysis SentimentPositive
Last Price839.00

Price Trends

50DMA781.52Positive
100DMA772.12Positive
200DMA796.76Positive

Market Momentum

MACD15.70Positive
RSI65.15Neutral
STOCH48.64Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9273, the sentiment is Positive. The current price of 839.00 is above the 20-day moving average (MA) of 814.20, above the 50-day MA of 781.52, and above the 200-day MA of 796.76, indicating a bullish trend. The MACD of 15.70 indicates Positive momentum. The RSI at 65.15 is Neutral, neither overbought nor oversold. The STOCH value of 48.64 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9273.

Koa Shoji Holdings Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:9273 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:9273JP:927383OutperformJPY 35.34B9.43―2.15%6.06%3.04%
JP:8129JP:812971OutperformJPY 261.44B15.85―5.24%3.55%-25.21%
JP:4534JP:453468NeutralJPY 111.78B12.676.64%2.51%14.72%52.55%
JP:4540JP:454065NeutralJPY 292.34B9.439.68%4.14%10.38%19.96%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:4887JP:488752NeutralJPY 166.10B22.10―3.36%11.08%701.86%

* General Sector Average

Performance Comparison

-20%0%20%JP:9273JP:4540JP:4534JP:4887JP:8129Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
JP:9273 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:9273Koa Shoji Holdings Co., Ltd.839.0075.579.90%
JP:4540Tsumura & Co3821.00390.6511.39%
JP:4534Mochida Pharmaceutical Co., Ltd.3285.00406.9714.14%
JP:4887SAWAI GROUP HOLDINGS Co., Ltd.1666.50-120.38-6.74%
JP:8129Toho Holdings Co., Ltd.4004.00-712.33-15.10%

Koa Shoji Holdings Co., Ltd. Corporate Events

KOA Shoji Holdings Updates Capital-Efficient Management Focus

Sep 17, 2026

KOA Shoji Holdings Co., Ltd., a TSE Prime-listed company supporting pharmaceuticals from upstream, is refining its management approach with a sharper focus on capital efficiency and market valuation. The company’s activities indicate a role in...

Koa Shoji Holdings Outlines Financial Results and Medium- to Long-Term Strategy

Aug 7, 2026

Koa Shoji Holdings Co., Ltd., active in the upstream pharmaceuticals domain, emphasizes supporting drug-related businesses through products and services that underpin pharmaceutical development and supply. The company targets a role as a key partner...

Koa Shoji Holdings Posts Higher Sales and Profits, Plans Dividend Hike Despite Forecast Profit Dip

Aug 7, 2026

Koa Shoji Holdings reported consolidated net sales of ¥24.68 billion for the fiscal year ended June 30, 2026, up 6.1% year on year, with operating profit rising 2.3% to ¥5.48 billion and profit attributable to owners of parent increasing 3....

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 17, 2026